Neoplasms Metastasis Completed Phase 3 Trials for Docetaxel (DB01248)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00190489A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast CancerTreatment
NCT00519285Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate CancerTreatment